
Novartis Texas Groundbreaking Marks Fifth US Radioligand Therapy Site in $23 Billion Expansion
Novartis has broken ground on a purpose-built 46,000 sq. ft. radioligand therapy (RLT) manufacturing facility in Denton, Texas, marking a pivotal step in the Swiss pharmaceutical giant’s $23 billion commitment to expanding its United…























